Juno Therapeutics junotherapeutics.com


Public list: BIO 2016 (619) Pharma Startups (6570) Cancer Therapeutics (1180)

Juno Therapeutics is a clinical-stage company that brings together three of the world's leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center, and Seattle Children's Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs. The CAR technology is designed to target cell ...Show all

Juno Therapeutics is a clinical-stage company that brings together three of the world's leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center, and Seattle Children's Research Institute – in unique...Show all

Company (Acquired)

Phone: 206-582-1600

Fax:

400 Dexter Avenue North
Suite 1200
Seattle, 98109
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Juno Therapeutics $310M Mar 6, 2018
Kite Pharma $212.8M Oct 3, 2017
Stemcentrx $520M Apr 28, 2016
See all 4 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Juno Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors
See all 4 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antibodies and chimeric antigen receptors specific for ror1 Jun 04, 2018 Jan 12, 2021 Patent
Engineered cells for adoptive cell therapy Jul 15, 2016 Sep 29, 2020 Patent
Engineered cells for adoptive cell therapy Jul 15, 2015 Aug 11, 2020 Patent
Antibodies and chimeric antigen receptors specific for cd19 Aug 28, 2015 Jan 14, 2020 Patent
Methods and compositions for dosing in adoptive cell therapy Oct 20, 2015 Dec 17, 2019 Patent
See all 73 patents